Global and health-related quality of life after intensity-modulated radiation therapy for head and neck cancer

Clayton B. Hess, Allen M. Chen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This study aims to evaluate the current literature regarding the effects of conventional radiation therapy (CRT) versus intensity-modulated radiation therapy (IMRT) on global quality of life (QoL) among patients treated for head and neck cancer. A PubMed literature review was performed. Only articles comparing global QoL scores in head and neck cancer patients treated with CRT versus IMRT were included. Studies were scrutinized for methodology, level of evidence and limitations. Outcomes were evaluated for external validity, level of evidence and applicability. Between 2005 and 2012, 14 eligible studies (six prospective, two randomized controlled trials) were identified. Although all presented data comment on the advantages of IMRT, differences in study design made comparisons difficult. The vast majority of these were also limited by relatively small sample sizes and heterogeneity with respect to patient and treatment-related characteristics. Although more robust evidence is needed in the future, the published data reasonably support the benefits of IMRT as compared with CRT (either 2D or 3D) in improving QoL, beginning at approximately 3-6 months post-treatment, and possibly potentiating with time up to 2 and 3 years.

Original languageEnglish (US)
Pages (from-to)1469-1477
Number of pages9
JournalExpert Review of Anticancer Therapy
Volume12
Issue number11
DOIs
StatePublished - Nov 2012

Fingerprint

Head and Neck Neoplasms
Radiotherapy
Quality of Life
Global Health
PubMed
Sample Size
Randomized Controlled Trials
Prospective Studies
Therapeutics

Keywords

  • head and neck cancer
  • intensity-modulated radiation therapy
  • quality of life

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Global and health-related quality of life after intensity-modulated radiation therapy for head and neck cancer. / Hess, Clayton B.; Chen, Allen M.

In: Expert Review of Anticancer Therapy, Vol. 12, No. 11, 11.2012, p. 1469-1477.

Research output: Contribution to journalArticle

@article{48ba8b935b824fe19638c96192c2a3fa,
title = "Global and health-related quality of life after intensity-modulated radiation therapy for head and neck cancer",
abstract = "This study aims to evaluate the current literature regarding the effects of conventional radiation therapy (CRT) versus intensity-modulated radiation therapy (IMRT) on global quality of life (QoL) among patients treated for head and neck cancer. A PubMed literature review was performed. Only articles comparing global QoL scores in head and neck cancer patients treated with CRT versus IMRT were included. Studies were scrutinized for methodology, level of evidence and limitations. Outcomes were evaluated for external validity, level of evidence and applicability. Between 2005 and 2012, 14 eligible studies (six prospective, two randomized controlled trials) were identified. Although all presented data comment on the advantages of IMRT, differences in study design made comparisons difficult. The vast majority of these were also limited by relatively small sample sizes and heterogeneity with respect to patient and treatment-related characteristics. Although more robust evidence is needed in the future, the published data reasonably support the benefits of IMRT as compared with CRT (either 2D or 3D) in improving QoL, beginning at approximately 3-6 months post-treatment, and possibly potentiating with time up to 2 and 3 years.",
keywords = "head and neck cancer, intensity-modulated radiation therapy, quality of life",
author = "Hess, {Clayton B.} and Chen, {Allen M.}",
year = "2012",
month = "11",
doi = "10.1586/era.12.126",
language = "English (US)",
volume = "12",
pages = "1469--1477",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "11",

}

TY - JOUR

T1 - Global and health-related quality of life after intensity-modulated radiation therapy for head and neck cancer

AU - Hess, Clayton B.

AU - Chen, Allen M.

PY - 2012/11

Y1 - 2012/11

N2 - This study aims to evaluate the current literature regarding the effects of conventional radiation therapy (CRT) versus intensity-modulated radiation therapy (IMRT) on global quality of life (QoL) among patients treated for head and neck cancer. A PubMed literature review was performed. Only articles comparing global QoL scores in head and neck cancer patients treated with CRT versus IMRT were included. Studies were scrutinized for methodology, level of evidence and limitations. Outcomes were evaluated for external validity, level of evidence and applicability. Between 2005 and 2012, 14 eligible studies (six prospective, two randomized controlled trials) were identified. Although all presented data comment on the advantages of IMRT, differences in study design made comparisons difficult. The vast majority of these were also limited by relatively small sample sizes and heterogeneity with respect to patient and treatment-related characteristics. Although more robust evidence is needed in the future, the published data reasonably support the benefits of IMRT as compared with CRT (either 2D or 3D) in improving QoL, beginning at approximately 3-6 months post-treatment, and possibly potentiating with time up to 2 and 3 years.

AB - This study aims to evaluate the current literature regarding the effects of conventional radiation therapy (CRT) versus intensity-modulated radiation therapy (IMRT) on global quality of life (QoL) among patients treated for head and neck cancer. A PubMed literature review was performed. Only articles comparing global QoL scores in head and neck cancer patients treated with CRT versus IMRT were included. Studies were scrutinized for methodology, level of evidence and limitations. Outcomes were evaluated for external validity, level of evidence and applicability. Between 2005 and 2012, 14 eligible studies (six prospective, two randomized controlled trials) were identified. Although all presented data comment on the advantages of IMRT, differences in study design made comparisons difficult. The vast majority of these were also limited by relatively small sample sizes and heterogeneity with respect to patient and treatment-related characteristics. Although more robust evidence is needed in the future, the published data reasonably support the benefits of IMRT as compared with CRT (either 2D or 3D) in improving QoL, beginning at approximately 3-6 months post-treatment, and possibly potentiating with time up to 2 and 3 years.

KW - head and neck cancer

KW - intensity-modulated radiation therapy

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=84871291005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871291005&partnerID=8YFLogxK

U2 - 10.1586/era.12.126

DO - 10.1586/era.12.126

M3 - Article

C2 - 23249111

AN - SCOPUS:84871291005

VL - 12

SP - 1469

EP - 1477

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 11

ER -